Photo from wikipedia
Oncotype DX recurrence score (RS) is a clinically validated assay, which predicts the likelihood of disease recurrence in oestrogen receptor‐positive/HER2‐negative (ER+/HER2−) breast cancer (BC). In this study we aimed to… Click to show full abstract
Oncotype DX recurrence score (RS) is a clinically validated assay, which predicts the likelihood of disease recurrence in oestrogen receptor‐positive/HER2‐negative (ER+/HER2−) breast cancer (BC). In this study we aimed to compare the performance of Oncotype DX against the conventional clinicopathological parameters using a large BC cohort diagnosed in a single institution.
Keywords:
clinicopathological parameters;
oncotype gene;
recurrence score;
recurrence;
gene recurrence;
evaluation oncotype
Journal Title: Histopathology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Histopathology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!